long term side effects of glp 1 agonists Mapping the effectiveness and risks GLP-1 receptor GLP-1 receptor agonists and next-generation
Description
Silva YP, Bernardi A, Frozza RL
Other medications include Invokana (canagliflozin), Jardiance (empagliflozin), and Glyxambi (empagliflozin/linagliptin)
BMJ (2015) 350:g7607
p-heterogeneity=0.90), and chronic kidney disease progression (HR 0.65
